Registry of Toxic Effects of Chemical Substances (RTECS)
Sulfuric acid, dimethyl ester
RTECS #
WS8225000CAS #
77-78-1Updated
September 201Molecular Weight
126.14Molecular Formula
C2H6O4SSynonyms
Dimethyl monosulfateDimethyl sulfate
Dimethyl sulfate (ACGIH:OSHA)
Dimethyl sulphate
Dimethylester kyseliny sirove (Czech)
Dimethylsulfaat (Dutch)
Dimethylsulfat (Czech)
Dimetilsolfato (Italian)
DMS (methyl sulfate)
Dwumetylowy siarczan (Polish)
Methyl sulfate
Methyle (sulfate de) (French)
RCRA waste number U103
Sulfate de methyle (French)
Sulfate dimethylique (French)
Skin and Eye Irritation and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
eye /rabbit | 100 mg/4S rinse | severe | FCTOD7 20,573,1982 |
eye /rabbit | 50 µg/24H | severe | 85JCAE -,1079,1986 |
skin /rabbit | 10 mg/24H open irritation test | severe | AMIHBC 4,119,1951 |
Mutation Data and Reference
System Test | Route/Organism/Tissue | Dose | Reference |
---|---|---|---|
body fluid assay | ovary/rat | 300 mg/kg | MUREAV 143,263,1985 |
Cytogenetic Analysis | intraperitoneal/rat | 350 mg/kg | NASLDX 3,187,1980 |
Cytogenetic Analysis | inhalation/rat | 290 µg/m3/16W | GTPZAB 30(9),38,1986 |
Cytogenetic Analysis | unreported route/human | 2 mg/m3 | MUREAV 147,301,1985 |
Cytogenetic Analysis | inhalation/mouse | 240 µg/m3/10W | GTPZAB 30(9),38,1986 |
Cytogenetic Analysis | Ascites tumor/mouse | 10 mmol/L | BIZNAT 88,49,1970 |
Cytogenetic Analysis | lung/hamster | 50 µmol/L | CRNGDP 3,385,1982 |
DNA adduct | Ascites tumor/mouse | 5 µmol/L | MUREAV 89,95,1981 |
DNA adduct | intraperitoneal/mouse | 30 mg/kg | CALEDQ 146,155,1999 |
DNA adduct | inhalation/rat | 0.1 ppm/6H | INHTE5 16,581,2004 |
DNA adduct | HeLa cell/human | 5 µmol/L | MUREAV 89,95,1981 |
DNA adduct | /Escherichia coli | 5 µmol/L | MUREAV 89,95,1981 |
DNA Damage | /Other microorganisms | 100 mmol/L | CBINA8 14,101,1976 |
DNA Damage | /Other microorganisms | 200 mg/L | CBINA8 13,151,1976 |
DNA Damage | /Bacillus subtilis | 130 mmol/L | MUREAV 9,141,1970 |
DNA Damage | lymphocyte/human | 1 mmol/L | JACTDZ 1(3),125,1982 |
DNA Damage | fibroblast/human | 100 µmol/L | CRNGDP 4,559,1983 |
DNA Damage | liver/rat | 100 µmol/L/3H | MUREAV 629,49,2007 |
DNA Damage | /Saccharomyes cerevisiae | 13.3 mg/L/17H | MUREAV 633,80,2007 |
DNA Damage | intraperitoneal/mouse | 100 mg/kg | MUREAV 467,83,2000 |
DNA Damage | intravenous/rat | 80 mg/kg | MUREAV 75,63,1980 |
DNA Damage | liver/rat | 30 µmol/L | MUREAV 189,69,1987 |
DNA Damage | inhalation/mouse | 20 µg/kg | PCBPBS 6,101,1976 |
DNA Damage | lung/hamster | 800 µmol/L/1H-continuous | CRNGDP 1,795,1980 |
DNA inhibition | oral/mouse | 20 gm/kg | ARGEAR 51,605,1981 |
DNA inhibition | intraperitoneal/mouse | 100 mg/kg | MUREAV 46,305,1977 |
DNA inhibition | HeLa cell/human | 2 mmol/L | MUREAV 92,427,1982 |
DNA inhibition | fibroblast/human | 75 µmol/L | CRNGDP 4,559,1983 |
DNA repair | /Escherichia coli | 331 µmol/L | MUREAV 272,145,1992 |
DNA repair | /Other microorganisms | 640 µg/plate | BIZNAT 95,463,1976 |
gene conversion and mitotic recombination | /Saccharomyes cerevisiae | 1900 µmol/L | SOGEBZ 17,915,1981 |
host-mediated assay | Salmonella typhimurium/mouse | 2500 µmol/kg | CBINA8 19,241,1977 |
micronucleus test | ovary/hamster | 58.5 mg/L/24H | MUREAV 633,80,2007 |
micronucleus test | intraperitoneal/mouse | 12500 µg/kg/48H- intermittent | MUREAV 389,3,1997 |
mutation in mammalian somatic cells | ovary/hamster | 20 µmol/L | MUREAV 57,217,1978 |
mutation in mammalian somatic cells | lung/hamster | 1 mg/L/1H | CRNGDP 1,175,1980 |
mutation in microorganisms | /Schizosaccharomyces pombe | 590 µmol/L (-enzymatic activation step) | CBINA8 14,195,1976 |
mutation in microorganisms | /Neurospora crassa | 1000 ppm/13M (-enzymatic activation step) | GENTAE 67,189,1971 |
mutation in microorganisms | /Saccharomyes cerevisiae | 500 ppm/12M (-enzymatic activation step) | GENTAE 78,1101,1974 |
mutation in microorganisms | /Other microorganisms | 1000 ppm/13M (-enzymatic activation step) | GENTAE 67,189,1971 |
mutation in microorganisms | /Other microorganisms | 250 ppm (-enzymatic activation step) | SOGEBZ 8,412,1972 |
mutation in microorganisms | /Other microorganisms | 2 mmol/L (-enzymatic activation step) | HEREAY 46,279,1960 |
mutation in microorganisms | /Salmonella typhimurium | 10 µmol/plate (+enzymatic activation step) | CBINA8 19,241,1977 |
mutation in microorganisms | /Salmonella typhimurium | 4300 nmol/L/1H (-enzymatic activation step) | PNASA6 75,4465,1978 |
mutation in microorganisms | /Escherichia coli | 20 µmol/L (-enzymatic activation step) | ARTODN 46,277,1980 |
other mutation test systems | /Escherichia coli | 2 nmol/tube | PNASA6 79,5971,1982 |
other mutation test systems | /Salmonella typhimurium | 38 mg/L | MUREAV 192,239,1987 |
other mutation test systems | /Other microorganisms | 100 mmol/L | CBINA8 14,101,1976 |
phage inhibition capacity | /Escherichia coli | 65 mmol/L | PRLBA4 150,497,1959 |
sex chromosome loss and nondisjunction | oral/Drosophila melanogaster | 3800 µmol/L | NATUAS 203,1404,1964 |
sister chromatid exchange | lung/hamster | 10 µmol/L | CRNGDP 3,385,1982 |
sister chromatid exchange | fibroblast/human | 1 µmol/L | MUREAV 75,63,1980 |
specific locus test | oral/Drosophila melanogaster | 5 mmol/L | MUREAV 182,243,1987 |
Unscheduled DNA Synthesis | lymphocyte/human | 10 µmol/L | CRNGDP 13,1285,1992 |
Unscheduled DNA Synthesis | fibroblast/human | 50 µmol/L | CRNGDP 4,559,1983 |
Unscheduled DNA Synthesis | HeLa cell/human | 400 µmol/L | MUREAV 139,155,1984 |
Unscheduled DNA Synthesis | lung/hamster | 40 mg/L | CBINA8 15,117,1976 |
Unscheduled DNA Synthesis | liver/rat | 100 µmol/L | ENMUDM 3,11,1981 |
Reproductive Effects Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
intravenous/rat | 100 mg/kg (15D pregnant) | Reproductive: Effects on embryo or fetus: Fetal death | IARCCD 4,45,1973 |
Tumorigenic Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/rat | lowest published toxic concentration: 17 mg/m3/19W- intermittent | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Olfaction: Tumors Blood: Lymphoma including Hodgkin's disease | ZEKBAI 74,241,1970 |
intravenous/rat | lowest published toxic dose: 20 mg/kg (15D pregnant) | Tumorigenic: Carcinogenic by RTECS criteria Reproductive: Tumorigenic effects: Transplacental tumorigenesis Brain and Coverings: Tumors | IARCCD 4,45,1973 |
subcutaneous/rat | lowest published toxic dose: 50 mg/kg | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Tumorigenic: Tumors at site of application | ZEKBAI 74,241,1970 |
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/guinea pig | lethal concentration (50 percent kill): 32 ppm/1H | 85JCAE -,1079,1986 | |
inhalation/human | Lowest published lethal concentration: 97 ppm/10M | 34ZIAG -,226,1969 | |
inhalation/mouse | lethal concentration (50 percent kill): 280 mg/m3 | Olfaction: Other olfaction effects Behavioral: Somnolence (general depressed activity) Lung, Thorax, or Respiration: Respiratory depression | GTPZAB 23(3),28,1979 |
inhalation/rat | lethal concentration (50 percent kill): 45 mg/m3/4H | Lung, Thorax, or Respiration: Dyspnea Lung, Thorax, or Respiration: Cyanosis Blood: Hemorrhage | GTPZAB 24(11),55,1980 |
intravenous/rabbit | lowest published lethal dose: 50 mg/kg | Behavioral: Muscle contraction or spasticity | AEXPBL 47,113,1902 |
oral/mouse | lethal dose (50 percent kill): 140 mg/kg | GTPZAB 23(3),28,1979 | |
oral/rabbit | lowest published lethal dose: 45 mg/kg | Behavioral: Food intake (animal) | AEXPBL 47,113,1902 |
oral/rat | lethal dose (50 percent kill): 205 mg/kg | GTPZAB 23(3),28,1979 | |
subcutaneous/rabbit | lowest published lethal dose: 53 mg/kg | Behavioral: Muscle contraction or spasticity Skin: After systemic exposure: Dermatitis, other | AEXPBL 47,113,1902 |
subcutaneous/rat | lethal dose (50 percent kill): 100 mg/kg | ZEKBAI 74,241,1970 |
Other Multiple Dose Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/rat | lowest published toxic concentration: 1.5 ppm/5D- intermittent | Nutritional and Gross Metabolic: Weight loss or decreased weight gain | INHTE5 16,581,2004 |
inhalation/rat | lowest published toxic concentration: 0.7 ppm/2W- intermittent | Olfaction: Ulcerated nasal septum Olfaction: Other olfaction effects Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation | INHTE5 16,581,2004 |
Reviews
Organization | Standard | Reference |
---|---|---|
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 0.1 ppm (skin) | DTLVS* TLV/BEI,2013 |
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-Confirmed animal carcinogen | DTLVS* TLV/BEI,2013 |
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Sufficient Evidence | IMEMDT 4,271,1974 |
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Sufficient Evidence | IMEMDT 71,575,1999 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human Inadequate Evidence | IMEMDT 4,271,1974 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human Inadequate Evidence | IMEMDT 71,575,1999 |
International Agency for Research on Cancer (IARC) | Cancer Review:Group 2A | IMEMDT 71,575,1999 |
TOXICOLOGY REVIEW | 85CVA2 5,63,1970 | |
TOXICOLOGY REVIEW | MUREAV 543,201,2003 | |
TOXICOLOGY REVIEW | CHHSA* 9,6,2002 | |
TOXICOLOGY REVIEW | FCTOD7 44,1699,2006 | |
TOXICOLOGY REVIEW | MUREAV 721,27,2011 | |
TOXICOLOGY REVIEW | MUTAEX 25,3,2010 |
Standards and Regulations
Organization | Standard | Reference |
---|---|---|
Mine Safety and Health Administration (MSHA) STANDARD-air | time-weighted average 1 ppm (5 mg/m3) (skin) | DTLVS* 3,92,1971 |
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV; | ||
Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLV | ||
Occupational Exposure Limit-AUSTRALIA | time-weighted average 0.1 ppm (0.52 mg/m3), Carcinogen, JUL2008 | |
Occupational Exposure Limit-AUSTRIA | TRK-TMW 0.02 ppm (0.1 mg/m3);KZW 0.08 ppm (0.4 mg/m3), skin, production, 2007 | |
Occupational Exposure Limit-AUSTRIA | TRK-TMW 0.04 ppm (0.2 mg/m3);KZW 0.16 ppm (0.8 mg/m3), skin, use and handl, 2007 | |
Occupational Exposure Limit-BELGIUM | time-weighted average 0.1 ppm (0.53 mg/m3), Skin, Carcinogen, MAR2002 | |
Occupational Exposure Limit-DENMARK | time-weighted average 0.01 ppm (0.05 mg/m3), skin, carc, MAY2011 | |
Occupational Exposure Limit-FINLAND | short term exposure limit 0.01 ppm (0.052 mg/m3), skin, NOV2011 | |
Occupational Exposure Limit-FRANCE | VME 0.1 ppm (0.5 mg/m3), C2 Carcinogen, FEB2006 | |
Occupational Exposure Limit-HUNGARY | ceiling concentration 0.1 mg/m3, Skin, Carcinogen, SEP2000 | |
Occupational Exposure Limit-ICELAND | time-weighted average 0.01 ppm (0.05 mg/m3), carc, skin, NOV2011 | |
Occupational Exposure Limit-JAPAN | Occupational Exposure Limit 0.1 ppm (0.52 mg/m3), skin, 2A carc, MAY2012 | |
Occupational Exposure Limit-KOREA | time-weighted average 0.1 ppm (0.5 mg/m3), skin, 2006 | |
Occupational Exposure Limit-MEXICO | time-weighted average 0.1 ppm (0.52 mg/m3), 2004 | |
Occupational Exposure Limit-NEW ZEALAND | time-weighted average 0.05 ppm (0.26 mg/m3), skin, JAN2002 | |
Occupational Exposure Limit-NORWAY | time-weighted average 0.01 ppm (0.05 mg/m3), JAN1999 | |
Occupational Exposure Limit-PERU | time-weighted average 0.1 ppm (0.52 mg/m3), JUL2005 | |
Occupational Exposure Limit-POLAND | MAC(time-weighted average) 0.5 mg/m3, MAC(short term exposure limit) 1 mg/m3, JAN1999 | |
Occupational Exposure Limit-RUSSIA | short term exposure limit 0.1 mg/m3, Skin, JUN2003 | |
Occupational Exposure Limit-SWEDEN | Group B Carcinogen, JUN2005 | |
Occupational Exposure Limit-SWITZERLAND | MAK-week 0.02 ppm (0.1 mg/m3), carc 2, skin, JAN2011 | |
Occupational Exposure Limit-TURKEY | time-weighted average 0.1 ppm (0.5 mg/m3), Skin, JAN1993 | |
Occupational Exposure Limit-UNITED KINGDOM | time-weighted average 0.05 ppm (0.26 mg/m3), skin, OCT2007 | |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction) | 8H time-weighted average 1 ppm (5 mg/m3) (skin) | CFRGBR 29,1926.55,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors) | 8H time-weighted average 1 ppm (5 mg/m3) (skin) | CFRGBR 41,50-204.50,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry) | 8H time-weighted average 1 ppm (5 mg/m3) (skin) | CFRGBR 29,1910.1000,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards) | 8H time-weighted average 1 ppm (5 mg/m3) (skin) | CFRGBR 29,1915.1000,1993 |
NIOSH Documentation and Surveillance
Organization | Standard | Reference |
---|---|---|
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO DIMETHYL SULFATE-air | 8H Carcinogen time-weighted average 0.1 ppm (Sk) | NIOSH* DHHS #92-100,1992 |
National Occupational Exposure Survey 1983 | Hazard Code 26880; Number of Industries 5; Total Number of Facilities 185; Number of Occupations 23; Total Number of Employees Exposed 10481; Total Number of Female Employees Exposed 2455 | |
National Occupational Hazard Survey 1974 | Hazard Code 26880; Number of Industries 3; Total Number of Facilities 83; Number of Occupations 5; Total Number of Employees Exposed 1249 |
Status in Federal Agencies
Organization | Reference |
---|---|
EPA GENETOX PROGRAM 1988, Inconclusive: Histidine reversion-Ames test | |
EPA GENETOX PROGRAM 1988, Negative: D melanogaster-partial sex chrom. loss | |
EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-human | |
EPA GENETOX PROGRAM 1988, Positive: Aspergillus-forward mutation; Carcinogenicity-mouse/rat | |
EPA GENETOX PROGRAM 1988, Positive: D melanogaster-reciprocal translocation | |
EPA GENETOX PROGRAM 1988, Positive: D melanogaster-whole sex chrom. loss | |
EPA GENETOX PROGRAM 1988, Positive: Host-mediated assay; E coli polA without S9 | |
EPA GENETOX PROGRAM 1988, Positive: In vitro cytogenetics-nonhuman | |
EPA GENETOX PROGRAM 1988, Positive: In vitro SCE-nonhuman; D melanogaster Sex-linked lethal | |
EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-reversion; S pombe-reversion | |
EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE | FEREAC 47,26992,82 |
EPA TSCA Section 8(b) CHEMICAL INVENTORY | |
EPA TSCA Section 8(d) unpublished health/safety studies | |
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001 | |
NIOSH Analytical Method, 1994: Dimethyl sulfate, 2524 | |
NTP 11th Report on Carcinogens,2004:Reasonably anticipated to be a human carcinogen | |
On EPA IRIS database |
- Page last reviewed:March 7, 2014
- Page last updated:February 6, 2017
- Content source:
- National Institute for Occupational Safety and Health (NIOSH) Education and Information Division